AJPB staff

The 77th Annual Scientific Sessions of the American Diabetes Association is being held in San Diego June 9 through June 13

The lincosamide antibacterial clindamycin in saline is the third premix from Baxter to receive FDA approval since August 2015.

Top articles of the week from The American Journal of Pharmacy Benefits.

Benralizumab led to a significant reduction in the use of oral corticosteroids for patients with severe, uncontrolled eosinophilic asthma.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week from The American Journal of Pharmacy Benefits.

The Senate has confirmed President Donald Trump's pick, Scott Gottlieb, MD, to lead the FDA.

Radicava is an intravenous infusion for the treatment of amyotrophic lateral sclerosis (ALS).

Top articles of the week from The American Journal of Pharmacy Benefits.

Buprenorphine and naloxone buccal film (Bunavail) approved for a revised indication to include use for the initiation of buprenorphine treatment for opioid dependence.

Campylobacter and Salmonella caused the most reported bacterial foodborne illnesses in 2016.

Generic version of olmesartan medoxomil and hydrochlorothiazide tablets treat hypertension to lower blood pressure.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

FDA approves the first noninvasive vagus nerve stimulation device approved for the acute treatment of pain from episodic cluster headache.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

Study evaluates intranasal oxytocin as a pharmacologic intervention for patients with post-traumatic stress disorder.

Soluble epoxide hydrolase may play a role in the pathogenesis of certain psychiatric diseases.

Raltegravir may help boost adherence and help prevent vaginal HIV transmission.

Top news of the day across the healthcare landscape.